Concepedia

Lukas Sprenger

LS

2

Publications

311

Citations

2

H-Index

2021

Active since

Affiliations

Clinical Research Institute(Current)

Lukas Sprenger is an author at Clinical Research Institute specializing in medicine, cardiovascular disease, and public health.

Top concepts

MedicinePublic HealthCardiovascular DiseaseDiabetesCardiologyThrombosisEpidemiologyPharmacologyHealth PolicyHeart Failure

Publications per year

2021–2022

2

Publications

2

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease

Lukas Sprenger, ARTHUR MADER, BARBARA LARCHER et al. · BMJ Open Diabetes Research & Care · 2021 · 15 citations · Full text

Heart Failure, Cardiometabolic Risk, Preventive Cardiology +19

Rows per page

1–2 of 2